Literature DB >> 18446313

Incidence of central nervous system involvement in chronic lymphocytic leukemia and outcome to treatment.

M C J Hanse1, M B Van't Veer, K van Lom, M J van den Bent.   

Abstract

Leptomeningeal involvement in patients with CLL is relatively rare and the prognosis is usually considered to be poor. The authors reviewed all CLL patients treated in a tertiary referral center to assess the incidence and outcome of leptomeningeal involvement (LI) in CLL. They found an incidence of 1-2% of LI. Most of the patients with LI had a longterm survival, despite failure to clear the cerebrospinal fluid from tumor cells.

Entities:  

Mesh:

Year:  2008        PMID: 18446313     DOI: 10.1007/s00415-008-0710-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  7 in total

1.  Chronic lymphocytic leukaemia with symptomatic diffuse central nervous system infiltration responding to therapy with systemic fludarabine.

Authors:  M A Elliott; L Letendre; C Y Li; J D Hoyer; J E Hammack
Journal:  Br J Haematol       Date:  1999-03       Impact factor: 6.998

2.  Meningeal involvement in leukemias and malignant lymphomas of adults: incidence, course of disease, and treatment for prevention.

Authors:  M Weizsaecker; H W Koelmel
Journal:  Acta Neurol Scand       Date:  1979-12       Impact factor: 3.209

3.  Remission of leukaemic meningitis after fludarabine.

Authors:  R Paolini; E Ramazzina; R Zennaro; A P Rimondi; G E Petracca; S Zamboni
Journal:  Lancet       Date:  1995-10-07       Impact factor: 79.321

4.  Fludarabine may induce durable remission in patients with leptomeningeal involvement of chronic lymphocytic leukemia.

Authors:  Stefan Knop; Ulrich Herrlinger; Ulrike Ernemann; Lothar Kanz; Holger Hebart
Journal:  Leuk Lymphoma       Date:  2005-11

Review 5.  Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies.

Authors:  Marco Montillo; Terry Hamblin; Michael Hallek; Emili Montserrat; Enrica Morra
Journal:  Haematologica       Date:  2005-03       Impact factor: 9.941

6.  An autopsy study of 1206 acute and chronic leukemias (1958 to 1982).

Authors:  M Barcos; W Lane; G A Gomez; T Han; A Freeman; H Preisler; E Henderson
Journal:  Cancer       Date:  1987-08-15       Impact factor: 6.860

Review 7.  Chronic lymphocytic leukemia and the central nervous system: a clinical and pathological study.

Authors:  S C Cramer; J A Glaspy; J T Efird; D N Louis
Journal:  Neurology       Date:  1996-01       Impact factor: 9.910

  7 in total
  14 in total

1.  Leptomeningeal Carcinomatosis in Chronic Lymphocytic Leukemia: A Case Report and Review of the Literature.

Authors:  Alipi V Naydenov; Lynne P Taylor
Journal:  Oncologist       Date:  2019-03-06

2.  Chronic lymphocytic leukemia with central nervous system involvement: report of two cases with a comprehensive literature review.

Authors:  Alan A Moazzam; Jan Drappatz; Ryan Y Kim; Santosh Kesari
Journal:  J Neurooncol       Date:  2011-07-17       Impact factor: 4.130

Review 3.  Neurological Complications of the Leukemias Across the Ages.

Authors:  Stephanie Berg; Sucha Nand
Journal:  Curr Neurol Neurosci Rep       Date:  2017-02       Impact factor: 5.081

4.  Chronic lymphocytic leukemia with central nervous system involvement: a high-risk disease?

Authors:  Ohad Benjamini; Preetesh Jain; Ellen Schlette; Jade S Sciffman; Zeev Estrov; Michael Keating
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2013-01-16

5.  Antiglycine receptor-related stiff limb syndrome in a patient with chronic lymphocytic leukaemia.

Authors:  Angelika Derksen; Mark Stettner; Winfried Stöcker; Rüdiger J Seitz
Journal:  BMJ Case Rep       Date:  2013-05-20

6.  Chronic Lymphocytic Leukemia Resulting in Hemorrhagic Brain Masses After Sepsis.

Authors:  Aaron M Gusdon; Sung-Min Cho; Yunis Mayasi; Rachna Malani; Hans A Püttgen; Amy Duffield; Javier Bolaños-Meade; Michael Lim
Journal:  Neurohospitalist       Date:  2019-07-02

7.  EBV related cerebral lymphoma in a leukemia patient treated with alemtuzumab.

Authors:  B van de Langerijt; J K Doorduijn; K H Lam; M J van den Bent
Journal:  J Neurol       Date:  2010-12-07       Impact factor: 4.849

8.  Chronic lymphocytic leukemia with clinical debut as neurological involvement: a rare phenomenon and the need for better predictive markers.

Authors:  Cristhiam M Rojas-Hernandez; Jacklyn Nemunaitis; Kristopher D Marjon; Daniel Bustamante; Qian-Yun Zhang; Jennifer M Gillette
Journal:  BMC Hematol       Date:  2017-02-02

9.  Hearing Loss due to Infiltration of the Tympanic Membrane by Chronic Lymphocytic Leukemia.

Authors:  Jonathon B Cohen; Robert Cavaliere; John C Byrd; Leslie A Andritsos
Journal:  Case Rep Hematol       Date:  2012-11-07

Review 10.  Leptomeningeal involvement in B-cell chronic lymphocytic leukemia: a case report and review of the literature.

Authors:  Simone Lima de Souza; Fábio Santiago; Marilza de Moura Ribeiro-Carvalho; Adriano Arnóbio; Andréa Ribeiro Soares; Maria Helena Ornellas
Journal:  BMC Res Notes       Date:  2014-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.